These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3937050)

  • 1. Genetic determinants of dyslipidemias.
    Breslow JL
    Monogr Atheroscler; 1985; 13():25-31. PubMed ID: 3937050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disorders of apolipoproteins and lipoprotein receptors].
    Itakura H; Matsumoto A
    Nihon Rinsho; 1990 Nov; 48(11):2666-74. PubMed ID: 2125327
    [No Abstract]   [Full Text] [Related]  

  • 3. [Apolipoproteinopathies].
    Assmann G
    Klin Wochenschr; 1983 Feb; 61(4):169-82. PubMed ID: 6405080
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic mutations affecting human lipoprotein metabolism.
    Zannis VI; Breslow JL
    Adv Hum Genet; 1985; 14():125-215, 383-6. PubMed ID: 2986430
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dyslipoproteinemias and coronary disease. Genetic markers].
    Sarriá Chueca A; Moreno Aznar L; Bueno Lozano G; Bueno Sánchez M
    An Esp Pediatr; 1989 Jun; 30(6):425-8. PubMed ID: 2572193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method to screen apolipoprotein polymorphisms in whole plasma: description of apolipoprotein A-IV variants in dyslipidemias and a reassessment of apolipoprotein A-I in Tangier disease.
    Bisgaier CL; Lee ES; Glickman RM
    Biochim Biophys Acta; 1987 Apr; 918(3):242-9. PubMed ID: 3105587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein disorders.
    Assmann G; Menzel HJ
    Ric Clin Lab; 1982; 12(1):63-81. PubMed ID: 6806887
    [No Abstract]   [Full Text] [Related]  

  • 8. Classification of primary dyslipoproteinemias.
    Dargel R
    Exp Pathol; 1985; 27(2):67-78. PubMed ID: 3888651
    [No Abstract]   [Full Text] [Related]  

  • 9. The significance of apolipoprotein variants.
    Menzel HJ; Utermann G
    Prog Clin Biol Res; 1988; 255():63-72. PubMed ID: 2963348
    [No Abstract]   [Full Text] [Related]  

  • 10. Human apolipoprotein molecular biology and genetic variation.
    Breslow JL
    Annu Rev Biochem; 1985; 54():699-727. PubMed ID: 3896129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interaction between genes and diet as a determinant of the plasma levels of cholesterol].
    López Miranda J; Ordovás JM; Pérez Jiménez F
    Med Clin (Barc); 1998 Oct; 111(14):546-51. PubMed ID: 9859082
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA polymorphisms as potential genetic risk markers for cardiovascular diseases.
    Cocozza S; Monticelli A; Garofalo S; Riccardi G; Cortese R; Quirico N; Ricci A; Cicerone R; Rossi F; Varrone S
    Boll Soc Ital Biol Sper; 1987 Sep; 63(9):771-7. PubMed ID: 2896009
    [No Abstract]   [Full Text] [Related]  

  • 13. [Classification of dyslipoproteinemias of genetic origin].
    Brousseau T; Fruchart JC
    Ann Med Interne (Paris); 1993; 144(4):275-81. PubMed ID: 8368721
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular variants of the lipoproteins.
    Galton DJ; Stocks J; Rees A
    Clin Sci (Lond); 1983 Jun; 64(6):559-63. PubMed ID: 6404583
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetics of lipoprotein disorders.
    Breslow JL
    Circulation; 1993 Apr; 87(4 Suppl):III16-21. PubMed ID: 8462176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of the apolipoprotein genes.
    Breslow JL
    Adv Exp Med Biol; 1985; 183():121-4. PubMed ID: 3839966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction enzyme analysis of the apolipoprotein A-I gene in fish eye disease and Tangier disease.
    Rees A; Stocks J; Schoulders C; Carlson LA; Baralle FE; Galton DJ
    Acta Med Scand; 1984; 215(3):235-7. PubMed ID: 6428166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical disorders of lipoprotein metabolism.
    Brewer HB; Gregg RE; Hoeg JM; Law S
    Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557
    [No Abstract]   [Full Text] [Related]  

  • 19. Insufficient evidence to invoke defects in or around the A-I gene as the cause for familial hypoalphalipoproteinemia.
    Hayden MR; Kastelein JJ; Langlois S
    Atherosclerosis; 1987 Oct; 67(2-3):271-2. PubMed ID: 3118895
    [No Abstract]   [Full Text] [Related]  

  • 20. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification.
    Zannis VI; Breslow JL
    Biochemistry; 1981 Feb; 20(4):1033-41. PubMed ID: 6260135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.